Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lymphoma, Mantle-Cell × Axitinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 24 Kidney Neoplasms 10 Neoplasms 9 Carcinoma 6 Colorectal Neoplasms 5 Carcinoma, Hepatocellular 5 Carcinoma, Non-Small-Cell Lung 4 Recurrence 3 Neoplasm Metastasis 3 Melanoma 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Lung Neoplasms 2 Kidney Diseases 2 Glioblastoma 2 Carcinoma, Adenoid Cystic 2 Breast Neoplasms 2 Advanced Solid Tumors 2 cT2a N0NxM0 Renal Tumor 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Solitary Fibrous Tumors 1 Solid Tumors 1 Solid Malignancies 1 Skin Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Refractory or Recurrent Solid Tumors, Excluding CNS Tumors 1 Prostatic Neoplasms 1

Interventions

Rituximab 134 Cyclophosphamide 125 Peripheral Blood Stem Cell Transplantation 73 fludarabine phosphate 71 Filgrastim 62 Etoposide 55 Bortezomib 44 Vincristine 43 Mycophenolic Acid 43 Whole-Body Irradiation 42 Cytarabine 42 Cyclosporine 41 Melphalan 38 Doxorubicin 37 Radiotherapy 36 Busulfan 35 ibrutinib 34 Tacrolimus 34 Methotrexate 33 Prednisone 32 Lenalidomide 30 Bendamustine Hydrochloride 30 Antilymphocyte Serum 27 Dexamethasone 26 Carmustine 25 Granulocyte Colony-Stimulating Factor 23 ibritumomab tiuxetan 20 sargramostim 17 fludarabine 17 Methylprednisolone 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00700258 2024-09-23

STAR-TOR

Pfizer

1,520 enrolled 24 charts

Carcinoma, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡